Cargando…
The Role of Nanovaccine in Cross-Presentation of Antigen-Presenting Cells for the Activation of CD8(+) T Cell Responses
Explosive growth in nanotechnology has merged with vaccine development in the battle against diseases caused by bacterial or viral infections and malignant tumors. Due to physicochemical characteristics including size, viscosity, density and electrostatic properties, nanomaterials have been applied...
Autores principales: | Kim, Cheol Gyun, Kye, Yoon-Chul, Yun, Cheol-Heui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6920862/ https://www.ncbi.nlm.nih.gov/pubmed/31731667 http://dx.doi.org/10.3390/pharmaceutics11110612 |
Ejemplares similares
-
Enhancement of Immune Responses Elicited by Nanovaccines through a Cross-Presentation Pathway
por: Kim, Cheol-Gyun, et al.
Publicado: (2023) -
Engineering anti-cancer nanovaccine based on antigen cross-presentation
por: Warrier, Vaishnavi U., et al.
Publicado: (2019) -
Cytomembrane nanovaccines show therapeutic effects by mimicking tumor cells and antigen presenting cells
por: Liu, Wen-Long, et al.
Publicado: (2019) -
Liposome-Coupled Antigens Are Internalized by Antigen-Presenting Cells via Pinocytosis and Cross-Presented to CD8(+) T Cells
por: Tanaka, Yuriko, et al.
Publicado: (2010) -
Viral Sequestration of Antigen Subverts Cross Presentation to CD8(+) T Cells
por: Tewalt, Eric F., et al.
Publicado: (2009)